Breast Tumours: WHO Classification of Tumours (Medicine)

Breast Tumours: WHO Classification of Tumours (Medicine), 5th Edition – A Key Resource in Tumor Classification

“Breast Tumours,” the second volume in the 5th edition of the WHO series on the classification of human tumors, is an essential reference for professionals involved in the diagnosis, treatment, and research of breast tumors. As part of the WHO Blue Books series, this edition is recognized as the gold standard in tumor classification. Key features of this book include:

1. Authoritative Reference: Provides a comprehensive and authoritative synthesis of histopathological diagnosis with digital and molecular pathology.

2. International Standards: Offers indispensable standards for the care of patients with cancer and underpins research in cancer causation, prevention, therapy, and education.

3. Expert Contributions: Compiled by leading experts in the field, ensuring the content is both reliable and current.

4. Valuable for Multiple Disciplines: Especially useful for pathologists, oncologists, surgeons, and epidemiologists who work with or research breast tumors.

5. Inclusive Coverage: Includes sections on all recognized neoplasms of the breast, including the nipple and areola.

6. Updated Information: Reflects recent changes based on molecular and genetic information with implications for clinical practice.

7. Counterfeit Warning: Notifies readers of potential counterfeit copies, especially when purchasing online, and advises buying from known sellers.

8. Clinical and Research Utility: Serves as a critical tool for both individual patient treatment and broad cancer research.

9. WHO Blue Books Series: Part of a renowned series known for its high standards in cancer diagnosis and classification.

“Breast Tumours: WHO Classification of Tumours, 5th Edition” is more than just a medical textbook; it’s a crucial resource for understanding the complex classification of breast tumors. This book is fundamental for ensuring accurate diagnosis and effective treatment planning in the management of breast cancer, as well as for facilitating advanced research in the field.

From the book :